Use of preoperative per rectal misoprostol in reducing intraoperative blood loss in LSCS

A randomized control study to determine the efficacy of preoperative per rectal misoprostol in reducing blood loss in LSCS - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075280

Enrollment

200

Registered

2024-10-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Intervention1: Per rectal misoprostol: Preoperative per rectal misoprostol Tab. Misoprostol 800 mcg after successful anesthetic induction of LSCS Control Intervention1: AMTSL: 10 units of oxytocin int

Eligibility

Inclusion criteria

Inclusion criteria: Consenting women undergoing lower segment cesarean section in KIMS during study period

Exclusion criteria

Exclusion criteria: Women known to have hypersensitivity to prostaglandin. Medical contraindications for prostaglandin. Women not consenting for trial

Design outcomes

Primary

Measure	Time frame
To study the effect of preoperative per rectal misoprostol in reducing intraoperative blood loss in lower segment cesarean section.Timepoint: immediate post operative.48 hours post operatively	—

Secondary

Measure	Time frame
To determine the use of pre operative misoprostol in reducing the incidence of PPH and there by reducing maternal mortality and morbidity.Timepoint: 2HRS AFTER LSCS	—

Countries

India

Contacts

Public ContactDR S V Nachikhata

Karnataka institute of medical science

svn1974@gmail.com9343882242

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026